LIGAND PHARMACEUTICALS INCORPORATED Sales and Excise Tax Payable, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) had Sales and Excise Tax Payable, Current of $1.75 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:SalesAndExciseTaxPayableCurrent · last filed 2026-02-27
- 2025-12-31: Sales and Excise Tax Payable, Current $1.75M.
- 2024-12-31: Sales and Excise Tax Payable, Current $5.16M.
| Period end | Sales and Excise Tax Payable, Current |
|---|---|
| 2025-12-31 | $1.75M 10-K · filed 2026-02-27 |
| 2024-12-31 | $5.16M 10-K · filed 2026-02-27 |